Buzard; Daniel J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Buzard; Daniel J..The latest application filed is for "processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclopenta[b]indol-3-yl)acetic acid and salts thereof".

Company Profile

13.37.52

Buzard; Daniel J. - San Diego CA
Buzard; Daniel J - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MAGL inhibitors Grant 11,434,222 - Wiener , et al. September 6, 2	2022-09-06
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20220259627 - Montalban; Antonio Garrido ; et al.	2022-08-18
Abhd12 Inhibitors And Methods Of Making And Using Same App 20220213074 - GRICE; Cheryl A. ; et al.	2022-07-07
Magl Inhibitors App 20220153721 - WIENER; John J.M. ; et al.	2022-05-19
MAGL inhibitors Grant 11,332,453 - Grice , et al. May 17, 2	2022-05-17
Magl Inhibitors App 20220135563 - GRICE; Cheryl A. ; et al.	2022-05-05
MAGL inhibitors Grant 11,214,557 - Grice , et al. January 4, 2	2022-01-04
Compounds Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20210340104 - Sadeque; Abu J.M. ; et al.	2021-11-04
Spirocycle compounds and methods of making and using same Grant 11,161,856 - Grice , et al. November 2, 2	2021-11-02
Pyrazole MAGL inhibitors Grant 11,149,037 - Grice , et al. October 19, 2	2021-10-19
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclopenta[B]indol-3-yl)acetic acid and salts thereof Grant 11,149,292 - Montalban , et al. October 19, 2	2021-10-19
Spirocycle compounds and methods of making and using same Grant 11,142,526 - Grice , et al. October 12, 2	2021-10-12
Spirocycle Compounds And Methods Of Making And Using Same App 20210214375 - GRICE; Cheryl A. ; et al.	2021-07-15
MAGL inhibitors Grant 11,059,822 - Grice , et al. July 13, 2	2021-07-13
Magl Inhibitors App 20210206735 - GRICE; Cheryl A. ; et al.	2021-07-08
Crystalline Forms Of A Magl Inhibitor App 20210147367 - GRICE; Cheryl A. ; et al.	2021-05-20
Piperazine carbamates and methods of making and using same Grant 10,899,737 - Grice , et al. January 26, 2	2021-01-26
SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20200407316 - Jones; Robert M. ; et al.	2020-12-31
Spirocycle compounds and methods of making and using same Grant 10,781,211 - Buzard , et al. Sept	2020-09-22
Magl Inhibitors App 20200291023 - GRICE; Cheryl A. ; et al.	2020-09-17
Spirocycle Compounds And Methods Of Making And Using Same App 20200255427 - Kind Code	2020-08-13
Magl Inhibitors App 20200148653 - GRICE; Cheryl A. ; et al.	2020-05-14
Pyrazole Magl Inhibitors App 20200087304 - GRICE; Cheryl A. ; et al.	2020-03-19
MAGL inhibitors Grant 10,570,106 - Grice , et al. Feb	2020-02-25
Spirocycle Compounds And Methods Of Making And Using Same App 20200022977 - BUZARD; Daniel J. ; et al.	2020-01-23
Magl Inhibitors App 20190352273 - GRICE; Cheryl A. ; et al.	2019-11-21
Piperazine Carbamates And Methods Of Making And Using Same App 20190202801 - GRICE; Cheryl A. ; et al.	2019-07-04
SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20190135752 - Jones; Robert M. ; et al.	2019-05-09
Spirocycle compounds and methods of making and using same Grant 10,030,020 - Cisar , et al. July 24, 2	2018-07-24
MAGL inhibitors Grant 9,981,930 - Grice , et al. May 29, 2	2018-05-29
Magl Inhibitors App 20180134675 - GRICE; Cheryl A. ; et al.	2018-05-17
Magl Inhibitors App 20180134674 - GRICE; Cheryl A. ; et al.	2018-05-17
Spirocycle Compounds And Methods Of Making And Using Same App 20170327500 - CISAR; Justin S. ; et al.	2017-11-16
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20170217885 - Jones; Robert M. ; et al.	2017-08-03
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20170159088 - Montalban; Antonio Garrido ; et al.	2017-06-08
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Grant 9,522,133 - Jones , et al. December 20, 2	2016-12-20
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocy- clopenta[B]indol-3-yl)acetic acid and salts thereof Grant 9,447,041 - Montalban , et al. September 20, 2	2016-09-20
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20160016904 - Montalban; Antonio Garrido ; et al.	2016-01-21
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20150336966 - Jones; Robert M. ; et al.	2015-11-26
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20150335618 - Jones; Robert M. ; et al.	2015-11-26
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocy- clopenta[B]indol-3-yl)acetic acid and salts thereof Grant 9,175,320 - Montalban , et al. November 3, 2	2015-11-03
Processes For The Preparation Of S1p1 Receptor Modulators And Crystalline Forms Thereof App 20150284399 - Jones; Robert M. ; et al.	2015-10-08
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Grant 9,126,932 - Jones , et al. September 8, 2	2015-09-08
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders Grant 9,108,969 - Jones , et al. August 18, 2	2015-08-18
Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof Grant 9,085,581 - Jones , et al. July 21, 2	2015-07-21
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20140357690 - Montalban; Antonio Garrido ; et al.	2014-12-04
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclopenta[b]indol-3-yl)acetic acid and salts thereof Grant 8,853,419 - Montalban , et al. October 7, 2	2014-10-07
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto App 20140066369 - Jones; Robert M. ; et al.	2014-03-06
SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS App 20140038987 - Jones; Robert M. ; et al.	2014-02-06
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders Grant 8,580,841 - Jones , et al. November 12, 2	2013-11-12
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20130184307 - Jones; Robert M. ; et al.	2013-07-18
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders Grant 8,415,484 - Jones , et al. April 9, 2	2013-04-09
Modulators Of The Gpr119 Receptor And The Treatment Of Disorders Related Thereto App 20130023494 - Jones; Robert M. ; et al.	2013-01-24
Processes For The Preparation Of S1p1 Receptor Modulators And Crystalline Forms Thereof App 20120329848 - Jones; Robert M. ; et al.	2012-12-27
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20120295947 - Montalban; Antonio Garrido ; et al.	2012-11-22
Imidazole compounds Grant 8,039,498 - Buzard , et al. October 18, 2	2011-10-18
Imidazole compounds Grant 8,017,639 - Buzard , et al. September 13, 2	2011-09-13
Imidazole compounds Grant 8,017,600 - Buzard , et al. September 13, 2	2011-09-13
Substituted Tricyclic Acid Derivatives As S1p1 Receptor Agonists Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20110160243 - Jones; Robert M. ; et al.	2011-06-30
Imidazole compounds Grant 7,956,071 - Buzard , et al. June 7, 2	2011-06-07
Imidazole compounds Grant 7,956,066 - Buzard , et al. June 7, 2	2011-06-07
Imidazole compounds Grant 7,956,057 - Buzard , et al. June 7, 2	2011-06-07
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic Acid Derivatives Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20110130409 - Jones; Robert M. ; et al.	2011-06-02
Imidazole compounds Grant 7,951,808 - Buzard , et al. May 31, 2	2011-05-31
Imidazole compounds Grant 7,928,131 - Buzard , et al. April 19, 2	2011-04-19
Dihydro-1h-pyrrolo[1,2-a]indol-1-yl Carboxylic Acid Derivatives Which Act As S1p1 Agonists App 20100292233 - Jones; Robert M. ; et al.	2010-11-18
Tetrahydrocyclopenta[b]indol-3-yl Carboxylic Acid Derivatives Useful In The Treatment Of Autoimmune And Inflammatory Disorders App 20100273806 - Jones; Robert M. ; et al.	2010-10-28
Imidazole Compounds App 20100261898 - BUZARD; Daniel J. ; et al.	2010-10-14
Imidazole Compounds App 20100261899 - Buzard; Daniel J. ; et al.	2010-10-14
Benzoimidazole compounds Grant 7,723,527 - Arienti , et al. May 25, 2	2010-05-25
Benzoimidazole compounds Grant 7,705,143 - Buzard , et al. April 27, 2	2010-04-27
Benzoimidazole compounds App 20090281307 - Arienti; Kristen L. ; et al.	2009-11-12
Benzoimidazole compounds App 20090264647 - Arienti; Kristen L. ; et al.	2009-10-22
Benzoimidazole compounds App 20090264645 - Buzard; Daniel J. ; et al.	2009-10-22
Imidazole compounds App 20070265250 - Buzard; Daniel J. ; et al.	2007-11-15
Imidazole compounds Grant 7,253,200 - Buzard , et al. August 7, 2	2007-08-07
Imidazole compounds App 20070173509 - Buzard; Daniel J. ; et al.	2007-07-26
Imidazole compounds App 20070173513 - Buzard; Daniel J. ; et al.	2007-07-26
Imidazole compounds App 20070173512 - Buzard; Daniel J. ; et al.	2007-07-26
Imidazole compounds App 20070173510 - Buzard; Daniel J. ; et al.	2007-07-26
Imidazole compounds App 20070149541 - Buzard; Daniel J. ; et al.	2007-06-28
Imidazole compounds App 20050261309 - Buzard, Daniel J. ; et al.	2005-11-24
Benzoimidazole compounds App 20050070550 - Arienti, Kristen L. ; et al.	2005-03-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.